Rapport Therapeutics (RAPP) Return on Equity [ROE] (2024 - 2026)
Rapport Therapeutics (RAPP) recorded Return on Equity [ROE] of -30.67% in Q2 2026, up 1.48 percentage points from -32.15% a year earlier but down 8.23 percentage points from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Return on Equity [ROE] (2024 - 2026) Analysis & Trends
For FY2025, Rapport Therapeutics reported Return on Equity [ROE] of -28.22%, up 27.75 percentage points from FY2024.
- Across earlier years, Return on Equity [ROE] came in at -55.97% in FY2024.
- Quarterly Return on Equity [ROE] has ranged from -37.43% in Q2 2024 to -19.53% in Q3 2024 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +1.16 percentage points over the last five quarters.
- Per Business Quant, the preceding three quarters came in at -22.44% (Q1 2026), -22.38% (Q4 2025) and -25.21% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Rapport Therapeutics | 1.54 Bn | 1.54 Bn | - | -30.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30.67% |
| Mar 31, 2026 | -22.44% |
| Dec 31, 2025 | -22.38% |
| Sep 30, 2025 | -25.21% |
| Jun 30, 2025 | -32.15% |
| Mar 31, 2025 | -26.96% |
| Dec 31, 2024 | -22.57% |
| Sep 30, 2024 | -19.53% |
| Jun 30, 2024 | -37.43% |
API Access
Rapport Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();